Remote Digital Technologies for the Early Detection and Monitoring of Cognitive Decline in Patients With Type 2 Diabetes: Insights From Studies of Neurodegenerative Diseases

被引：0
|
作者：
DuBord, Ashley Y. [1 ,2 ]
Paolillo, Emily W. [1 ]
Staffaroni, Adam M. [1 ]
机构：
[1] Univ Calif San Francisco, Weill Inst Neurosciences, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA
[2] 2 Diabet Technol Soc, Burlingame, CA USA
来源：
JOURNAL OF DIABETES SCIENCE AND TECHNOLOGY | 2024年 / 18卷 / 06期
关键词：
type; 2; diabetes; Alzheimer's disease; mild cognitive impairment; cognitive decline; digital biomarkers; health technology; ALZHEIMERS-DISEASE; AUTOMATIC DETECTION; OLDER-ADULTS; IMPAIRMENT; DEMENTIA; MELLITUS; BATTERY; INSULIN; RECOGNITION; PERFORMANCE;
D O I：
10.1177/19322968231171399
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Type 2 diabetes (T2D) is a risk factor for cognitive decline. In neurodegenerative disease research, remote digital cognitive assessments and unobtrusive sensors are gaining traction for their potential to improve early detection and monitoring of cognitive impairment. Given the high prevalence of cognitive impairments in T2D, these digital tools are highly relevant. Further research incorporating remote digital biomarkers of cognition, behavior, and motor functioning may enable comprehensive characterizations of patients with T2D and may ultimately improve clinical care and equitable access to research participation. The aim of this commentary article is to review the feasibility, validity, and limitations of using remote digital cognitive tests and unobtrusive detection methods to identify and monitor cognitive decline in neurodegenerative conditions and apply these insights to patients with T2D.
引用
收藏
页码：1489 / 1499
页数：11
相关论文
共 50 条
  • [21] Cross-sectional association of metrics derived from continuous glucose monitoring with cognitive performance in older adults with type 2 diabetes
    Sugimoto, Taiki
    Tokuda, Haruhiko
    Miura, Hisayuki
    Kawashima, Shuji
    Ando, Takafumi
    Kuroda, Yujiro
    Matsumoto, Nanae
    Fujita, Kosuke
    Uchida, Kazuaki
    Kishino, Yoshinobu
    Sakurai, Takashi
    DIABETES OBESITY & METABOLISM, 2023, 25 (01) : 222 - 228
  • [22] Untargeted Metabolomic Profiling Reveals Differentially Expressed Serum Metabolites and Pathways in Type 2 Diabetes Patients with and without Cognitive Decline: A Cross-Sectional Study
    Al-Akl, Neyla S.
    Khalifa, Olfa
    Ponirakis, Georgios
    Parray, Aijaz
    Ramadan, Marwan
    Khan, Shafi
    Chandran, Mani
    Ayadathil, Raheem
    Elsotouhy, Ahmed
    Own, Ahmed
    Al Hamad, Hanadi
    Decock, Julie
    Alajez, Nehad M.
    Albagha, Omar
    Malik, Rayaz A.
    El-Agnaf, Omar M. A.
    Arredouani, Abdelilah
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (04)
  • [23] Lobar Cerebral Microbleeds Are Associated With Cognitive Decline in Patients With Type 2 Diabetes Mellitus
    Shao, Pengfei
    Xu, Hengheng
    Sheng, Xiaoning
    Qin, Ruomeng
    Ma, Junyi
    Luo, Yishan
    Lee, Allan
    Shi, Lin
    Huang, Lili
    Cheng, Yue
    Zhao, Hui
    Xu, Yun
    FRONTIERS IN NEUROLOGY, 2022, 13
  • [24] The Potential for Correcting Cognitive Decline in Patients with Type 2 Diabetes Mellitus
    Khairullin I.K.
    Esin R.G.
    Pozdnyak A.O.
    Neuroscience and Behavioral Physiology, 2016, 46 (3) : 360 - 364
  • [25] Association of Depression With Accelerated Cognitive Decline Among Patients With Type 2 Diabetes in the ACCORD-MIND Trial
    Sullivan, Mark D.
    Katon, Wayne J.
    Lovato, Laura C.
    Miller, Michael E.
    Murray, Anne M.
    Horowitz, Karen R.
    Bryan, R. Nick
    Gerstein, Hertzel C.
    Marcovina, Santica
    Akpunonu, Basil E.
    Johnson, Janice
    Yale, Jean Francois
    Williamson, Jeff
    Launer, Lenore J.
    JAMA PSYCHIATRY, 2013, 70 (10) : 1041 - 1047
  • [26] In Addition to Poor Glycemic Control, a High Level of Irisin in the Plasma Portends Early Cognitive Deficits Clinically in Chinese Patients With Type 2 Diabetes Mellitus
    Lin, Hongyan
    Yuan, Yang
    Tian, Sai
    Han, Jing
    Huang, Rong
    Guo, Dan
    Wang, Jiaqi
    An, Ke
    Wang, Shaohua
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [27] Clinical and Subclinical Macrovascular Disease as Predictors of Cognitive Decline in Older Patients With Type 2 Diabetes: The Edinburgh Type 2 Diabetes Study
    Feinkohl, Insa
    Keller, Marketa
    Robertson, Christine M.
    Morling, Joanne R.
    Williamson, Rachel M.
    Nee, Lisa D.
    McLachlan, Stela
    Sattar, Naveed
    Welsh, Paul
    Reynolds, Rebecca M.
    Russ, Tom C.
    Deary, Ian J.
    Strachan, Mark W. J.
    Price, Jackie F.
    DIABETES CARE, 2013, 36 (09) : 2779 - 2786
  • [28] Longitudinal association of continuous glucose monitoring-derived metrics with cognitive decline in older adults with type 2 diabetes: A 1-year prospective observational study
    Sugimoto, Taiki
    Tokuda, Haruhiko
    Miura, Hisayuki
    Kawashima, Shuji
    Omura, Takuya
    Ando, Takafumi
    Kuroda, Yujiro
    Matsumoto, Nanae
    Fujita, Kosuke
    Uchida, Kazuaki
    Kishino, Yoshinobu
    Sakurai, Takashi
    DIABETES OBESITY & METABOLISM, 2023, 25 (12) : 3831 - 3836
  • [29] Health and Productivity Benefits with Early Intensified Treatment in Patients with Type 2 Diabetes: Results from Korea
    Tsotra, Foteini
    Malhotra, Ankur
    Peristeris, Platon
    Athanasiou, Ioannis
    Mueller, Malina
    Bader, Giovanni
    INQUIRY-THE JOURNAL OF HEALTH CARE ORGANIZATION PROVISION AND FINANCING, 2024, 61
  • [30] Olfactory Dysfunction Mediates Adiposity in Cognitive Impairment of Type 2 Diabetes: Insights From Clinical and Functional Neuroimaging Studies
    Zhang, Zhou
    Zhang, Bing
    Wang, Xin
    Zhang, Xin
    Yang, Qing X.
    Qing, Zhao
    Zhang, Wen
    Zhu, Dalong
    Bi, Yan
    DIABETES CARE, 2019, 42 (07) : 1274 - 1283
12345